Alexander Nowak
Stock Analyst at Craig-Hallum
(2.81)
# 1,670
Out of 5,240 analysts
46
Total ratings
47.37%
Success rate
7.99%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BVS Bioventus | Maintains: Buy | $15 → $16 | $10.61 | +50.80% | 7 | Mar 6, 2026 | |
| CELC Celcuity | Maintains: Buy | $96 → $108 | $134.72 | -19.83% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $5.74 | +283.28% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $196.91 | -20.27% | 4 | Nov 13, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $11.39 | +400.44% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $20.49 | -26.79% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.37 | +25.69% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.34 | +1,243.28% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $14.15 | +253.36% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $8.39 | +1,808.17% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.60 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.94 | +467.01% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $44.74 | +145.87% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $5.82 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $0.69 | +43,378.26% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $8.61 | +225.20% | 1 | Aug 31, 2020 |
Bioventus
Mar 6, 2026
Maintains: Buy
Price Target: $15 → $16
Current: $10.61
Upside: +50.80%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $134.72
Upside: -19.83%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $5.74
Upside: +283.28%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $196.91
Upside: -20.27%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $11.39
Upside: +400.44%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $20.49
Upside: -26.79%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.37
Upside: +25.69%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.34
Upside: +1,243.28%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $14.15
Upside: +253.36%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $8.39
Upside: +1,808.17%
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $4.60
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $1.94
Upside: +467.01%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $44.74
Upside: +145.87%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $5.82
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $0.69
Upside: +43,378.26%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $8.61
Upside: +225.20%